Gamida eyes cell therapy regulatory nod with Lonza partnership
Gamida continues its manufacturing agreement with Lonza for the future commercial production of its cell therapy, omidubicel.
Archives for June 20, 2019
Biogen tips its biosimilars to save EU payers €1.8bn in 2019
Biogen has predicted that its three biosimilars will save European healthcare systems €1.8bn this year.